Ignite Creation Date:
2025-12-24 @ 9:48 PM
Ignite Modification Date:
2026-05-24 @ 9:31 PM
Study NCT ID:
NCT05601232
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-04-09
First Post:
2022-10-27
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase II Study by Using CICS-1 and SPM-011 Commissioned by CICS and STELLA PHARMA
Sponsor:
Stella Pharma Corporation
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Unresectable Angiosarcoma | View |
Keywords: